Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An update of the molecular mechanisms underlying doxorubicin plus trastuzumab induced cardiotoxicity
Miguel Godinho de Oliveira Anjos, Marta Fontes Oliveira, Vera Marisa Costa, et al.
Life Sciences (2021) Vol. 280, pp. 119760-119760
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

The Research Progress of Trastuzumab-Induced Cardiotoxicity in HER-2-Positive Breast Cancer Treatment
Mengmeng Lin, Weiping Xiong, Shiyuan Wang, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 8
Open Access | Times Cited: 42
Doxorubicin-induced cardiotoxicity and risk factors
Carl W. Belger, Carmelita Abrahams, Aqeela Imamdin, et al.
IJC Heart & Vasculature (2023) Vol. 50, pp. 101332-101332
Open Access | Times Cited: 29
Berberine Alleviates Doxorubicin-Induced Myocardial Injury and Fibrosis by Eliminating Oxidative Stress and Mitochondrial Damage via Promoting Nrf-2 Pathway Activation
Yiyang Wang, Jia Liao, Yuanliang Luo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3257-3257
Open Access | Times Cited: 28
MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity
Ziyu Kuang, Jingyuan Wu, Ying Tan, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 568-568
Open Access | Times Cited: 17
Cell death regulation in myocardial toxicity induced by antineoplastic drugs
Xue Yu, Yan Yang, Tianzuo Chen, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 16
Recent Advances in Mitochondrial Fission/Fusion-Targeted Therapy in Doxorubicin-Induced Cardiotoxicity
Chayodom Maneechote, Siriporn C. Chattipakorn, Nipon Chattipakorn
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1182-1182
Open Access | Times Cited: 16
Nanomedicine And Nanotheranostics: Special Focus on Imaging of Anticancer Drugs Induced Cardiac Toxicity
Aseem Setia, Randheer Reddy Challa, Bhaskar Vallamkonda, et al.
Nanotheranostics (2024) Vol. 8, Iss. 4, pp. 473-496
Open Access | Times Cited: 5
Genetic factors in the pathogenesis of cardio-oncology
Yalong Qi, Yuhan Wei, Lixi Li, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
On-Target Side Effects of Targeted Therapeutics of Cancer
József Tı́már, Andrea Uhlyarik
Pathology & Oncology Research (2022) Vol. 28
Open Access | Times Cited: 22
Insights on the molecular targets of cardiotoxicity induced by anticancer drugs: A systematic review based on proteomic findings
Sofia Reis Brandão, Félix Carvalho, Francisco Amado, et al.
Metabolism (2022) Vol. 134, pp. 155250-155250
Open Access | Times Cited: 20
Cardiotoxicity in breast cancer treatment: Causes and mitigation
Deepthi Valiyaveettil, Deepa Joseph, Monica Malik
Cancer Treatment and Research Communications (2023) Vol. 37, pp. 100760-100760
Open Access | Times Cited: 13
Doxorubicin or Epirubicin Versus Liposomal Doxorubicin Therapy—Differences in Cardiotoxicity
Barbara Buchalska, Katarzyna Kamińska, Michał Kowara, et al.
Cardiovascular Toxicology (2025)
Closed Access
The Application and Molecular Mechanisms of Mitochondria-Targeted Antioxidants in Chemotherapy-Induced Cardiac Injury
Chih-Jen Liu, Lu‐Kai Wang, Fu‐Ming Tsai
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 3, pp. 176-176
Open Access
Cardiovascular adverse events associated with EGFR and HER2 dual TKIs: a pharmacovigilance study based on the FAERS database
Henan Qin, Yibin Teng, Peiyao Yu, et al.
Expert Opinion on Drug Safety (2025)
Closed Access
Understanding the Mechanisms of Chemotherapy-Related Cardiotoxicity Employing hiPSC-Derived Cardiomyocyte Models for Drug Screening and the Identification of Genetic and Epigenetic Variants
A Solomon, Swarna Dabral, R. G. Brajesh, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 3966-3966
Open Access
Preventive use of beta-blockers for anthracycline-induced cardiotoxicity: A network meta-analysis
Dongsheng He, Jun Hu, Ying Li, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 18
Precision Cardio-oncology: Update on Omics-Based Diagnostic Methods
Ziyu Kuang, Miao Kong, Ningzhe Yan, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 5, pp. 679-701
Open Access | Times Cited: 3
Mechanism of Astragalus membranaceus (Huangqi, HQ) for treatment of heart failure based on network pharmacology and molecular docking
Qiuxiang Chen, Juan Wang, Lihua Sun, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 10
Open Access | Times Cited: 3
Traditional Chinese medicine as a protective strategy against chemotherapy-induced cardiotoxicity: An overview of the literature
Junwei Wang, Hong Shao, You-Ni Zhang, et al.
Journal of Traditional and Complementary Medicine (2024) Vol. 15, Iss. 2, pp. 107-118
Open Access | Times Cited: 3
The Impairment of Cell Metabolism by Cardiovascular Toxicity of Doxorubicin Is Reversed by Bergamot Polyphenolic Fraction Treatment in Endothelial Cells
Cristina Algieri, Chiara Bernardini, Francesca Oppedisano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 8977-8977
Open Access | Times Cited: 12
Chemotherapy-related cardiotoxicity and its symptoms in patients with breast cancer: a scoping review
Hyunjoo Kim, Bomi Hong, Sanghee Kim, et al.
Systematic Reviews (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Melatonin and metformin ameliorated trastuzumab-induced cardiotoxicity through the modulation of mitochondrial function and dynamics without reducing its anticancer efficacy
Apiwan Arinno, Chayodom Maneechote, Thawatchai Khuanjing, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022) Vol. 1869, Iss. 2, pp. 166618-166618
Open Access | Times Cited: 10
Cardiac Molecular Remodeling by Anticancer Drugs: Doxorubicin Affects More Metabolism While Mitoxantrone Impacts More Autophagy in Adult CD-1 Male Mice
Sofia Reis Brandão, Ana Reis-Mendes, Margarida Duarte‐Araújo, et al.
Biomolecules (2023) Vol. 13, Iss. 6, pp. 921-921
Open Access | Times Cited: 6
Spectrum of National Institutes of Health-Funded Research in Cardio-Oncology
Bishow B. Adhikari, Scarlet Shi, Eileen Dimond, et al.
Heart Failure Clinics (2022) Vol. 18, Iss. 3, pp. 515-528
Open Access | Times Cited: 9
Polysaccharide guided tumor delivery of therapeutics: A bio-fabricated galactomannan-gold nanosystem for augmented cancer therapy
MG Archana, T.T. Sreelekha, H.P. Syama, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 80, pp. 104172-104172
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top